ACCC slams Sensaslim director
August 17, 2011
THE Australian Competition and
Consumer Commission has started
proceedings against Peter O’Brien,
the sole director of Sensaslim
Australia Pty Ltd (in liquidation),
alleging contempt of court.
The move follows interim orders
obtained by the ACCC in June to
preserve money held in the
Sensaslim bank account, with
material in support of the
application including information
from some of the franchisees of the
controversial weight-loss spray.
In a statement issued yesterday,
the ACCC said it’s alleging that
O’Brien authorised a communication
sent to franchisees of the company
“which had a tendency to interfere
with the administration of justice”.
The commission is seeking a
declaration, penalties and costs
against O’Brien.
A separate proceeding scheduled
for a hearing in court today alleges
that Sensaslim Australia and several
of its officers “engaged in
misleading and deceptive conduct
and made false representations”.
It’s believed that franchisees paid
up to $60,000 to sell the product
which was promoted as being
backed by evidence from a
“worldwide clinical trial”.
It later emerged that no such trial
had ever taken place.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Aug 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Aug 11
